nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ADRA2A—type 2 diabetes mellitus	0.112	0.42	CbGaD
Quetiapine—HTR2C—type 2 diabetes mellitus	0.103	0.387	CbGaD
Quetiapine—CYP3A4—type 2 diabetes mellitus	0.0514	0.193	CbGaD
Quetiapine—DRD5—Bromocriptine—type 2 diabetes mellitus	0.032	0.0714	CbGbCtD
Quetiapine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0235	0.0523	CbGbCtD
Quetiapine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0228	0.0509	CbGbCtD
Quetiapine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0206	0.0459	CbGbCtD
Quetiapine—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0188	0.0419	CbGbCtD
Quetiapine—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.018	0.0402	CbGbCtD
Quetiapine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.018	0.0402	CbGbCtD
Quetiapine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.017	0.0378	CbGbCtD
Quetiapine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0365	CbGbCtD
Quetiapine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0365	CbGbCtD
Quetiapine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0155	0.0346	CbGbCtD
Quetiapine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0292	CbGbCtD
Quetiapine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.012	0.0267	CbGbCtD
Quetiapine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0113	0.0252	CbGbCtD
Quetiapine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0241	CbGbCtD
Quetiapine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0241	CbGbCtD
Quetiapine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0103	0.0231	CbGbCtD
Quetiapine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00993	0.0222	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0086	0.0192	CbGbCtD
Quetiapine—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0086	0.0192	CbGbCtD
Quetiapine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00859	0.0192	CbGbCtD
Quetiapine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00807	0.018	CbGbCtD
Quetiapine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00766	0.0171	CbGbCtD
Quetiapine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00686	0.0153	CbGbCtD
Quetiapine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00686	0.0153	CbGbCtD
Quetiapine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00645	0.0144	CbGbCtD
Quetiapine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00633	0.0141	CbGbCtD
Quetiapine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00612	0.0137	CbGbCtD
Quetiapine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00554	0.0124	CbGbCtD
Quetiapine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00522	0.0116	CbGbCtD
Quetiapine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00515	0.0115	CbGbCtD
Quetiapine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00481	0.0107	CbGbCtD
Quetiapine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00459	0.0102	CbGbCtD
Quetiapine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0042	0.00937	CbGbCtD
Quetiapine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00398	0.00889	CbGbCtD
Quetiapine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00395	0.00883	CbGbCtD
Quetiapine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0038	0.00849	CbGbCtD
Quetiapine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00379	0.00846	CbGbCtD
Quetiapine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00367	0.00819	CbGbCtD
Quetiapine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00351	0.00784	CbGbCtD
Quetiapine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00332	0.0074	CbGbCtD
Quetiapine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00321	0.00717	CbGbCtD
Quetiapine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00283	0.00633	CbGbCtD
Quetiapine—ABCB1—Losartan—type 2 diabetes mellitus	0.00259	0.00579	CbGbCtD
Quetiapine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00251	0.00561	CbGbCtD
Quetiapine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00241	0.00538	CbGbCtD
Quetiapine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00241	0.00538	CbGbCtD
Quetiapine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00228	0.00509	CbGbCtD
Quetiapine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00175	0.0561	CbGeAlD
Quetiapine—HTR2A—arteriole—type 2 diabetes mellitus	0.00171	0.0549	CbGeAlD
Quetiapine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0017	0.00379	CbGbCtD
Quetiapine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00155	0.00347	CbGbCtD
Quetiapine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00117	0.0377	CbGeAlD
Quetiapine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00109	0.035	CbGeAlD
Quetiapine—DRD1—nerve—type 2 diabetes mellitus	0.00106	0.0339	CbGeAlD
Quetiapine—HTR3A—nerve—type 2 diabetes mellitus	0.00102	0.0328	CbGeAlD
Quetiapine—HTR1B—artery—type 2 diabetes mellitus	0.000863	0.0277	CbGeAlD
Quetiapine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000847	0.0272	CbGeAlD
Quetiapine—HTR1D—artery—type 2 diabetes mellitus	0.000835	0.0268	CbGeAlD
Quetiapine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000732	0.0235	CbGeAlD
Quetiapine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000677	0.0218	CbGeAlD
Quetiapine—HTR7—artery—type 2 diabetes mellitus	0.000665	0.0214	CbGeAlD
Quetiapine—HTR7—nerve—type 2 diabetes mellitus	0.00066	0.0212	CbGeAlD
Quetiapine—DRD2—nerve—type 2 diabetes mellitus	0.000624	0.0201	CbGeAlD
Quetiapine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000621	0.02	CbGeAlD
Quetiapine—HTR7—endothelium—type 2 diabetes mellitus	0.000562	0.0181	CbGeAlD
Quetiapine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000528	0.017	CbGeAlD
Quetiapine—H1F0—islet of Langerhans—type 2 diabetes mellitus	0.000518	0.0167	CbGeAlD
Quetiapine—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000494	0.0159	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000478	0.0154	CbGeAlD
Quetiapine—H1F0—retina—type 2 diabetes mellitus	0.000443	0.0142	CbGeAlD
Quetiapine—H1F0—nephron tubule—type 2 diabetes mellitus	0.000417	0.0134	CbGeAlD
Quetiapine—HTR2A—artery—type 2 diabetes mellitus	0.000415	0.0133	CbGeAlD
Quetiapine—HTR2A—nerve—type 2 diabetes mellitus	0.000412	0.0132	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000409	0.0132	CbGeAlD
Quetiapine—ADRA1B—kidney—type 2 diabetes mellitus	0.000388	0.0125	CbGeAlD
Quetiapine—H1F0—cardiovascular system—type 2 diabetes mellitus	0.000375	0.012	CbGeAlD
Quetiapine—H1F0—kidney—type 2 diabetes mellitus	0.000367	0.0118	CbGeAlD
Quetiapine—H1F0—pancreas—type 2 diabetes mellitus	0.000364	0.0117	CbGeAlD
Quetiapine—H1F0—cortex of kidney—type 2 diabetes mellitus	0.000357	0.0115	CbGeAlD
Quetiapine—HTR2A—endothelium—type 2 diabetes mellitus	0.00035	0.0113	CbGeAlD
Quetiapine—H1F0—adipose tissue—type 2 diabetes mellitus	0.00033	0.0106	CbGeAlD
Quetiapine—CYP3A7—liver—type 2 diabetes mellitus	0.000313	0.01	CbGeAlD
Quetiapine—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.0003	0.00964	CbGeAlD
Quetiapine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000298	0.00958	CbGeAlD
Quetiapine—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.00029	0.00933	CbGeAlD
Quetiapine—HTR1D—kidney—type 2 diabetes mellitus	0.000284	0.00913	CbGeAlD
Quetiapine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000271	0.00872	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000266	0.00854	CbGeAlD
Quetiapine—DRD2—retina—type 2 diabetes mellitus	0.000258	0.00831	CbGeAlD
Quetiapine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000246	0.0079	CbGeAlD
Quetiapine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000242	0.00778	CbGeAlD
Quetiapine—CHRM3—kidney—type 2 diabetes mellitus	0.000238	0.00764	CbGeAlD
Quetiapine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000237	0.0076	CbGeAlD
Quetiapine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000234	0.00754	CbGeAlD
Quetiapine—H1F0—liver—type 2 diabetes mellitus	0.000232	0.00745	CbGeAlD
Quetiapine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000231	0.00743	CbGeAlD
Quetiapine—HTR7—kidney—type 2 diabetes mellitus	0.000226	0.00727	CbGeAlD
Quetiapine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000223	0.00717	CbGeAlD
Quetiapine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000214	0.00688	CbGeAlD
Quetiapine—ADRA2C—kidney—type 2 diabetes mellitus	0.000208	0.00668	CbGeAlD
Quetiapine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000207	0.00664	CbGeAlD
Quetiapine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000203	0.00651	CbGeAlD
Quetiapine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000198	0.00636	CbGeAlD
Quetiapine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000197	0.00632	CbGeAlD
Quetiapine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000187	0.00602	CbGeAlD
Quetiapine—CYP3A5—kidney—type 2 diabetes mellitus	0.000174	0.00559	CbGeAlD
Quetiapine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000173	0.00556	CbGeAlD
Quetiapine—HTR2A—retina—type 2 diabetes mellitus	0.00017	0.00548	CbGeAlD
Quetiapine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000169	0.00545	CbGeAlD
Quetiapine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000165	0.0053	CbGeAlD
Quetiapine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000162	0.00519	CbGeAlD
Quetiapine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000161	0.0497	CrCbGaD
Quetiapine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000157	0.00504	CbGeAlD
Quetiapine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000152	0.00489	CbGeAlD
Quetiapine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.00015	0.00481	CbGeAlD
Quetiapine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000144	0.00463	CbGeAlD
Quetiapine—HTR7—liver—type 2 diabetes mellitus	0.000143	0.0046	CbGeAlD
Quetiapine—HTR2A—kidney—type 2 diabetes mellitus	0.000141	0.00453	CbGeAlD
Quetiapine—CYP2C19—liver—type 2 diabetes mellitus	0.00014	0.00449	CbGeAlD
Quetiapine—ADRA1A—liver—type 2 diabetes mellitus	0.000138	0.00443	CbGeAlD
Quetiapine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000137	0.0422	CrCbGaD
Quetiapine—ADRA2C—liver—type 2 diabetes mellitus	0.000131	0.00422	CbGeAlD
Quetiapine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000131	0.0042	CbGeAlD
Quetiapine—CYP3A4—kidney—type 2 diabetes mellitus	0.000131	0.0042	CbGeAlD
Quetiapine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.000129	0.0398	CrCbGaD
Quetiapine—CYP2D6—kidney—type 2 diabetes mellitus	0.000129	0.00413	CbGeAlD
Quetiapine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000127	0.0393	CrCbGaD
Quetiapine—Metixene—HTR2C—type 2 diabetes mellitus	0.000117	0.0361	CrCbGaD
Quetiapine—ABCB1—retina—type 2 diabetes mellitus	0.000112	0.00359	CbGeAlD
Quetiapine—CYP3A5—liver—type 2 diabetes mellitus	0.00011	0.00354	CbGeAlD
Quetiapine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000105	0.00338	CbGeAlD
Quetiapine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	9.78e-05	0.0302	CrCbGaD
Quetiapine—Nefazodone—ADRA2A—type 2 diabetes mellitus	9.73e-05	0.03	CrCbGaD
Quetiapine—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.45e-05	0.00304	CbGeAlD
Quetiapine—Olanzapine—ADRA2A—type 2 diabetes mellitus	9.32e-05	0.0288	CrCbGaD
Quetiapine—ABCB1—kidney—type 2 diabetes mellitus	9.24e-05	0.00297	CbGeAlD
Quetiapine—ABCB1—pancreas—type 2 diabetes mellitus	9.18e-05	0.00295	CbGeAlD
Quetiapine—ABCB1—cortex of kidney—type 2 diabetes mellitus	9e-05	0.00289	CbGeAlD
Quetiapine—Trazodone—ADRA2A—type 2 diabetes mellitus	9e-05	0.0278	CrCbGaD
Quetiapine—Nefazodone—HTR2C—type 2 diabetes mellitus	8.96e-05	0.0277	CrCbGaD
Quetiapine—HTR2A—liver—type 2 diabetes mellitus	8.92e-05	0.00287	CbGeAlD
Quetiapine—Olanzapine—HTR2C—type 2 diabetes mellitus	8.58e-05	0.0265	CrCbGaD
Quetiapine—Thiothixene—ADRA2A—type 2 diabetes mellitus	8.43e-05	0.0261	CrCbGaD
Quetiapine—ABCB1—adipose tissue—type 2 diabetes mellitus	8.33e-05	0.00268	CbGeAlD
Quetiapine—Trazodone—HTR2C—type 2 diabetes mellitus	8.29e-05	0.0256	CrCbGaD
Quetiapine—CYP3A4—liver—type 2 diabetes mellitus	8.25e-05	0.00265	CbGeAlD
Quetiapine—CYP2D6—liver—type 2 diabetes mellitus	8.12e-05	0.00261	CbGeAlD
Quetiapine—Thiothixene—HTR2C—type 2 diabetes mellitus	7.76e-05	0.024	CrCbGaD
Quetiapine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	7.42e-05	0.0229	CrCbGaD
Quetiapine—Amoxapine—ADRA2A—type 2 diabetes mellitus	7.41e-05	0.0229	CrCbGaD
Quetiapine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	7.29e-05	0.0225	CrCbGaD
Quetiapine—Amoxapine—HTR2C—type 2 diabetes mellitus	6.83e-05	0.0211	CrCbGaD
Quetiapine—Fluphenazine—HTR2C—type 2 diabetes mellitus	6.71e-05	0.0207	CrCbGaD
Quetiapine—Olanzapine—CYP1A2—type 2 diabetes mellitus	6.47e-05	0.02	CrCbGaD
Quetiapine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	5.86e-05	0.0181	CrCbGaD
Quetiapine—Thiothixene—CYP1A2—type 2 diabetes mellitus	5.86e-05	0.0181	CrCbGaD
Quetiapine—ABCB1—liver—type 2 diabetes mellitus	5.84e-05	0.00188	CbGeAlD
Quetiapine—Loxapine—ADRA2A—type 2 diabetes mellitus	5.79e-05	0.0179	CrCbGaD
Quetiapine—Perphenazine—ADRA2A—type 2 diabetes mellitus	5.76e-05	0.0178	CrCbGaD
Quetiapine—Mequitazine—CYP3A4—type 2 diabetes mellitus	5.45e-05	0.0168	CrCbGaD
Quetiapine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	5.36e-05	0.0166	CrCbGaD
Quetiapine—Loxapine—HTR2C—type 2 diabetes mellitus	5.33e-05	0.0165	CrCbGaD
Quetiapine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	5.32e-05	0.0164	CrCbGaD
Quetiapine—Perphenazine—HTR2C—type 2 diabetes mellitus	5.31e-05	0.0164	CrCbGaD
Quetiapine—Promazine—ADRA2A—type 2 diabetes mellitus	5.2e-05	0.016	CrCbGaD
Quetiapine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	5.06e-05	0.0156	CrCbGaD
Quetiapine—Clozapine—ADRA2A—type 2 diabetes mellitus	4.86e-05	0.015	CrCbGaD
Quetiapine—Promazine—HTR2C—type 2 diabetes mellitus	4.78e-05	0.0148	CrCbGaD
Quetiapine—Clozapine—HTR2C—type 2 diabetes mellitus	4.48e-05	0.0138	CrCbGaD
Quetiapine—Nefazodone—CYP3A4—type 2 diabetes mellitus	4.47e-05	0.0138	CrCbGaD
Quetiapine—Olanzapine—CYP3A4—type 2 diabetes mellitus	4.28e-05	0.0132	CrCbGaD
Quetiapine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.2e-05	0.000274	CcSEcCtD
Quetiapine—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.19e-05	0.000273	CcSEcCtD
Quetiapine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.18e-05	0.000273	CcSEcCtD
Quetiapine—Myalgia—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000272	CcSEcCtD
Quetiapine—Chest pain—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000272	CcSEcCtD
Quetiapine—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000272	CcSEcCtD
Quetiapine—Shock—Metformin—type 2 diabetes mellitus	4.18e-05	0.000272	CcSEcCtD
Quetiapine—Insomnia—Orlistat—type 2 diabetes mellitus	4.17e-05	0.000272	CcSEcCtD
Quetiapine—Malaise—Losartan—type 2 diabetes mellitus	4.17e-05	0.000272	CcSEcCtD
Quetiapine—Anxiety—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.000272	CcSEcCtD
Quetiapine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.16e-05	0.000271	CcSEcCtD
Quetiapine—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.16e-05	0.000271	CcSEcCtD
Quetiapine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.16e-05	0.000271	CcSEcCtD
Quetiapine—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.16e-05	0.000271	CcSEcCtD
Quetiapine—Vertigo—Losartan—type 2 diabetes mellitus	4.15e-05	0.000271	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000271	CcSEcCtD
Quetiapine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.15e-05	0.00027	CcSEcCtD
Quetiapine—Somnolence—Valsartan—type 2 diabetes mellitus	4.14e-05	0.00027	CcSEcCtD
Quetiapine—Syncope—Losartan—type 2 diabetes mellitus	4.14e-05	0.00027	CcSEcCtD
Quetiapine—Trazodone—CYP3A4—type 2 diabetes mellitus	4.14e-05	0.0128	CrCbGaD
Quetiapine—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.14e-05	0.00027	CcSEcCtD
Quetiapine—Leukopenia—Losartan—type 2 diabetes mellitus	4.14e-05	0.00027	CcSEcCtD
Quetiapine—Discomfort—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000269	CcSEcCtD
Quetiapine—Skin disorder—Metformin—type 2 diabetes mellitus	4.12e-05	0.000269	CcSEcCtD
Quetiapine—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000268	CcSEcCtD
Quetiapine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.1e-05	0.000268	CcSEcCtD
Quetiapine—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000268	CcSEcCtD
Quetiapine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000267	CcSEcCtD
Quetiapine—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.09e-05	0.000266	CcSEcCtD
Quetiapine—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000266	CcSEcCtD
Quetiapine—Palpitations—Losartan—type 2 diabetes mellitus	4.08e-05	0.000266	CcSEcCtD
Quetiapine—Nausea—Glimepiride—type 2 diabetes mellitus	4.07e-05	0.000265	CcSEcCtD
Quetiapine—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.06e-05	0.000265	CcSEcCtD
Quetiapine—Nausea—Sitagliptin—type 2 diabetes mellitus	4.06e-05	0.000264	CcSEcCtD
Quetiapine—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000264	CcSEcCtD
Quetiapine—Asthenia—Glyburide—type 2 diabetes mellitus	4.05e-05	0.000264	CcSEcCtD
Quetiapine—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.05e-05	0.000264	CcSEcCtD
Quetiapine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	4.05e-05	0.0125	CrCbGaD
Quetiapine—Anorexia—Metformin—type 2 diabetes mellitus	4.05e-05	0.000264	CcSEcCtD
Quetiapine—Cough—Losartan—type 2 diabetes mellitus	4.03e-05	0.000263	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.03e-05	0.000262	CcSEcCtD
Quetiapine—Fatigue—Valsartan—type 2 diabetes mellitus	4.02e-05	0.000262	CcSEcCtD
Quetiapine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.01e-05	0.000261	CcSEcCtD
Quetiapine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.01e-05	0.000261	CcSEcCtD
Quetiapine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000261	CcSEcCtD
Quetiapine—Decreased appetite—Orlistat—type 2 diabetes mellitus	4e-05	0.000261	CcSEcCtD
Quetiapine—Perphenazine—CYP1A2—type 2 diabetes mellitus	4e-05	0.0124	CrCbGaD
Quetiapine—Pruritus—Glyburide—type 2 diabetes mellitus	4e-05	0.000261	CcSEcCtD
Quetiapine—Mental disorder—Ramipril—type 2 diabetes mellitus	3.99e-05	0.00026	CcSEcCtD
Quetiapine—Constipation—Valsartan—type 2 diabetes mellitus	3.99e-05	0.00026	CcSEcCtD
Quetiapine—Infection—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000259	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.98e-05	0.000259	CcSEcCtD
Quetiapine—Fatigue—Orlistat—type 2 diabetes mellitus	3.97e-05	0.000259	CcSEcCtD
Quetiapine—Hypotension—Metformin—type 2 diabetes mellitus	3.97e-05	0.000259	CcSEcCtD
Quetiapine—Malnutrition—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000258	CcSEcCtD
Quetiapine—Shock—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000257	CcSEcCtD
Quetiapine—Pain—Orlistat—type 2 diabetes mellitus	3.94e-05	0.000257	CcSEcCtD
Quetiapine—Myalgia—Losartan—type 2 diabetes mellitus	3.93e-05	0.000256	CcSEcCtD
Quetiapine—Arthralgia—Losartan—type 2 diabetes mellitus	3.93e-05	0.000256	CcSEcCtD
Quetiapine—Chest pain—Losartan—type 2 diabetes mellitus	3.93e-05	0.000256	CcSEcCtD
Quetiapine—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.93e-05	0.000256	CcSEcCtD
Quetiapine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000256	CcSEcCtD
Quetiapine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000256	CcSEcCtD
Quetiapine—Anxiety—Losartan—type 2 diabetes mellitus	3.92e-05	0.000256	CcSEcCtD
Quetiapine—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000255	CcSEcCtD
Quetiapine—Rash—Bromocriptine—type 2 diabetes mellitus	3.9e-05	0.000254	CcSEcCtD
Quetiapine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.89e-05	0.000254	CcSEcCtD
Quetiapine—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000254	CcSEcCtD
Quetiapine—Tension—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000253	CcSEcCtD
Quetiapine—Discomfort—Losartan—type 2 diabetes mellitus	3.89e-05	0.000253	CcSEcCtD
Quetiapine—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000253	CcSEcCtD
Quetiapine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	3.88e-05	0.012	CrCbGaD
Quetiapine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000252	CcSEcCtD
Quetiapine—Headache—Bromocriptine—type 2 diabetes mellitus	3.87e-05	0.000252	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.87e-05	0.000252	CcSEcCtD
Quetiapine—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.87e-05	0.000252	CcSEcCtD
Quetiapine—Nervousness—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000251	CcSEcCtD
Quetiapine—Dry mouth—Losartan—type 2 diabetes mellitus	3.85e-05	0.000251	CcSEcCtD
Quetiapine—Anorexia—Irbesartan—type 2 diabetes mellitus	3.82e-05	0.000249	CcSEcCtD
Quetiapine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.81e-05	0.000249	CcSEcCtD
Quetiapine—Paraesthesia—Metformin—type 2 diabetes mellitus	3.81e-05	0.000249	CcSEcCtD
Quetiapine—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000248	CcSEcCtD
Quetiapine—Confusional state—Losartan—type 2 diabetes mellitus	3.8e-05	0.000248	CcSEcCtD
Quetiapine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.8e-05	0.000247	CcSEcCtD
Quetiapine—Dyspnoea—Metformin—type 2 diabetes mellitus	3.79e-05	0.000247	CcSEcCtD
Quetiapine—Somnolence—Metformin—type 2 diabetes mellitus	3.77e-05	0.000246	CcSEcCtD
Quetiapine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.77e-05	0.000246	CcSEcCtD
Quetiapine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.77e-05	0.000246	CcSEcCtD
Quetiapine—Infection—Losartan—type 2 diabetes mellitus	3.75e-05	0.000244	CcSEcCtD
Quetiapine—Hypotension—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000244	CcSEcCtD
Quetiapine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.74e-05	0.000244	CcSEcCtD
Quetiapine—Dyspepsia—Metformin—type 2 diabetes mellitus	3.74e-05	0.000244	CcSEcCtD
Quetiapine—Olanzapine—ALB—type 2 diabetes mellitus	3.74e-05	0.0115	CrCbGaD
Quetiapine—Tremor—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000242	CcSEcCtD
Quetiapine—Shock—Losartan—type 2 diabetes mellitus	3.71e-05	0.000242	CcSEcCtD
Quetiapine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	3.71e-05	0.0114	CrCbGaD
Quetiapine—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.7e-05	0.000241	CcSEcCtD
Quetiapine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.69e-05	0.000241	CcSEcCtD
Quetiapine—Decreased appetite—Metformin—type 2 diabetes mellitus	3.69e-05	0.000241	CcSEcCtD
Quetiapine—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.69e-05	0.00024	CcSEcCtD
Quetiapine—Tachycardia—Losartan—type 2 diabetes mellitus	3.68e-05	0.00024	CcSEcCtD
Quetiapine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.68e-05	0.00024	CcSEcCtD
Quetiapine—Nausea—Bromocriptine—type 2 diabetes mellitus	3.67e-05	0.000239	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.67e-05	0.000239	CcSEcCtD
Quetiapine—Fatigue—Metformin—type 2 diabetes mellitus	3.66e-05	0.000239	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.000238	CcSEcCtD
Quetiapine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.65e-05	0.000238	CcSEcCtD
Quetiapine—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.64e-05	0.000237	CcSEcCtD
Quetiapine—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.64e-05	0.000237	CcSEcCtD
Quetiapine—Asthenia—Gliclazide—type 2 diabetes mellitus	3.64e-05	0.000237	CcSEcCtD
Quetiapine—Agitation—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000237	CcSEcCtD
Quetiapine—Constipation—Metformin—type 2 diabetes mellitus	3.63e-05	0.000237	CcSEcCtD
Quetiapine—Angioedema—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000236	CcSEcCtD
Quetiapine—Promazine—CYP1A2—type 2 diabetes mellitus	3.61e-05	0.0111	CrCbGaD
Quetiapine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.6e-05	0.000235	CcSEcCtD
Quetiapine—Anorexia—Losartan—type 2 diabetes mellitus	3.59e-05	0.000234	CcSEcCtD
Quetiapine—Vomiting—Glyburide—type 2 diabetes mellitus	3.59e-05	0.000234	CcSEcCtD
Quetiapine—Pruritus—Gliclazide—type 2 diabetes mellitus	3.59e-05	0.000234	CcSEcCtD
Quetiapine—Malaise—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000233	CcSEcCtD
Quetiapine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000233	CcSEcCtD
Quetiapine—Rash—Glyburide—type 2 diabetes mellitus	3.56e-05	0.000232	CcSEcCtD
Quetiapine—Somnolence—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000232	CcSEcCtD
Quetiapine—Dermatitis—Glyburide—type 2 diabetes mellitus	3.56e-05	0.000232	CcSEcCtD
Quetiapine—Vertigo—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000232	CcSEcCtD
Quetiapine—Syncope—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000232	CcSEcCtD
Quetiapine—Clozapine—CYP2E1—type 2 diabetes mellitus	3.55e-05	0.011	CrCbGaD
Quetiapine—Leukopenia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000231	CcSEcCtD
Quetiapine—Headache—Glyburide—type 2 diabetes mellitus	3.54e-05	0.000231	CcSEcCtD
Quetiapine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.00023	CcSEcCtD
Quetiapine—Hypotension—Losartan—type 2 diabetes mellitus	3.52e-05	0.00023	CcSEcCtD
Quetiapine—Palpitations—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000228	CcSEcCtD
Quetiapine—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.5e-05	0.000228	CcSEcCtD
Quetiapine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.000227	CcSEcCtD
Quetiapine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000227	CcSEcCtD
Quetiapine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.47e-05	0.000226	CcSEcCtD
Quetiapine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.47e-05	0.000226	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.46e-05	0.000225	CcSEcCtD
Quetiapine—Cough—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000225	CcSEcCtD
Quetiapine—Fatigue—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000225	CcSEcCtD
Quetiapine—Thioproperazine—ALB—type 2 diabetes mellitus	3.44e-05	0.0106	CrCbGaD
Quetiapine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.44e-05	0.000224	CcSEcCtD
Quetiapine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.44e-05	0.000224	CcSEcCtD
Quetiapine—Convulsion—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000224	CcSEcCtD
Quetiapine—Pain—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000223	CcSEcCtD
Quetiapine—Constipation—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000223	CcSEcCtD
Quetiapine—Insomnia—Losartan—type 2 diabetes mellitus	3.41e-05	0.000222	CcSEcCtD
Quetiapine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.39e-05	0.000221	CcSEcCtD
Quetiapine—Paraesthesia—Losartan—type 2 diabetes mellitus	3.39e-05	0.000221	CcSEcCtD
Quetiapine—Thiothixene—ALB—type 2 diabetes mellitus	3.38e-05	0.0105	CrCbGaD
Quetiapine—Pipotiazine—ALB—type 2 diabetes mellitus	3.38e-05	0.0105	CrCbGaD
Quetiapine—Clozapine—CYP1A2—type 2 diabetes mellitus	3.38e-05	0.0104	CrCbGaD
Quetiapine—Chest pain—Ramipril—type 2 diabetes mellitus	3.37e-05	0.00022	CcSEcCtD
Quetiapine—Myalgia—Ramipril—type 2 diabetes mellitus	3.37e-05	0.00022	CcSEcCtD
Quetiapine—Arthralgia—Ramipril—type 2 diabetes mellitus	3.37e-05	0.00022	CcSEcCtD
Quetiapine—Dyspnoea—Losartan—type 2 diabetes mellitus	3.36e-05	0.000219	CcSEcCtD
Quetiapine—Anxiety—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000219	CcSEcCtD
Quetiapine—Nausea—Glyburide—type 2 diabetes mellitus	3.36e-05	0.000219	CcSEcCtD
Quetiapine—Abdominal pain—Metformin—type 2 diabetes mellitus	3.36e-05	0.000219	CcSEcCtD
Quetiapine—Dizziness—Gliclazide—type 2 diabetes mellitus	3.36e-05	0.000219	CcSEcCtD
Quetiapine—Somnolence—Losartan—type 2 diabetes mellitus	3.35e-05	0.000219	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000218	CcSEcCtD
Quetiapine—Asthenia—Valsartan—type 2 diabetes mellitus	3.35e-05	0.000218	CcSEcCtD
Quetiapine—Discomfort—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000217	CcSEcCtD
Quetiapine—Dyspepsia—Losartan—type 2 diabetes mellitus	3.32e-05	0.000216	CcSEcCtD
Quetiapine—Asthenia—Orlistat—type 2 diabetes mellitus	3.31e-05	0.000215	CcSEcCtD
Quetiapine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.3e-05	0.000215	CcSEcCtD
Quetiapine—Pruritus—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000215	CcSEcCtD
Quetiapine—Dry mouth—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000215	CcSEcCtD
Quetiapine—Decreased appetite—Losartan—type 2 diabetes mellitus	3.28e-05	0.000214	CcSEcCtD
Quetiapine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000214	CcSEcCtD
Quetiapine—Confusional state—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000213	CcSEcCtD
Quetiapine—Pruritus—Orlistat—type 2 diabetes mellitus	3.26e-05	0.000212	CcSEcCtD
Quetiapine—Fatigue—Losartan—type 2 diabetes mellitus	3.25e-05	0.000212	CcSEcCtD
Quetiapine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000211	CcSEcCtD
Quetiapine—Vomiting—Gliclazide—type 2 diabetes mellitus	3.23e-05	0.00021	CcSEcCtD
Quetiapine—Pain—Losartan—type 2 diabetes mellitus	3.22e-05	0.00021	CcSEcCtD
Quetiapine—Constipation—Losartan—type 2 diabetes mellitus	3.22e-05	0.00021	CcSEcCtD
Quetiapine—Rash—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000209	CcSEcCtD
Quetiapine—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000208	CcSEcCtD
Quetiapine—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.19e-05	0.000208	CcSEcCtD
Quetiapine—Shock—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000207	CcSEcCtD
Quetiapine—Headache—Gliclazide—type 2 diabetes mellitus	3.18e-05	0.000207	CcSEcCtD
Quetiapine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000207	CcSEcCtD
Quetiapine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000206	CcSEcCtD
Quetiapine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000206	CcSEcCtD
Quetiapine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000206	CcSEcCtD
Quetiapine—Tachycardia—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000206	CcSEcCtD
Quetiapine—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.15e-05	0.000205	CcSEcCtD
Quetiapine—Skin disorder—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000205	CcSEcCtD
Quetiapine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000204	CcSEcCtD
Quetiapine—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.11e-05	0.000203	CcSEcCtD
Quetiapine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.08e-05	0.000201	CcSEcCtD
Quetiapine—Dizziness—Valsartan—type 2 diabetes mellitus	3.08e-05	0.000201	CcSEcCtD
Quetiapine—Anorexia—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000201	CcSEcCtD
Quetiapine—Dizziness—Orlistat—type 2 diabetes mellitus	3.05e-05	0.000199	CcSEcCtD
Quetiapine—Asthenia—Metformin—type 2 diabetes mellitus	3.05e-05	0.000199	CcSEcCtD
Quetiapine—Hypotension—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000197	CcSEcCtD
Quetiapine—Nausea—Gliclazide—type 2 diabetes mellitus	3.01e-05	0.000196	CcSEcCtD
Quetiapine—Pruritus—Metformin—type 2 diabetes mellitus	3e-05	0.000196	CcSEcCtD
Quetiapine—Body temperature increased—Losartan—type 2 diabetes mellitus	2.98e-05	0.000194	CcSEcCtD
Quetiapine—Abdominal pain—Losartan—type 2 diabetes mellitus	2.98e-05	0.000194	CcSEcCtD
Quetiapine—Vomiting—Valsartan—type 2 diabetes mellitus	2.96e-05	0.000193	CcSEcCtD
Quetiapine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.95e-05	0.000192	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000192	CcSEcCtD
Quetiapine—Rash—Valsartan—type 2 diabetes mellitus	2.94e-05	0.000192	CcSEcCtD
Quetiapine—Dermatitis—Valsartan—type 2 diabetes mellitus	2.94e-05	0.000191	CcSEcCtD
Quetiapine—Vomiting—Orlistat—type 2 diabetes mellitus	2.93e-05	0.000191	CcSEcCtD
Quetiapine—Insomnia—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000191	CcSEcCtD
Quetiapine—Headache—Valsartan—type 2 diabetes mellitus	2.92e-05	0.00019	CcSEcCtD
Quetiapine—Diarrhoea—Metformin—type 2 diabetes mellitus	2.91e-05	0.000189	CcSEcCtD
Quetiapine—Rash—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000189	CcSEcCtD
Quetiapine—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000189	CcSEcCtD
Quetiapine—Dermatitis—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000189	CcSEcCtD
Quetiapine—Headache—Orlistat—type 2 diabetes mellitus	2.89e-05	0.000188	CcSEcCtD
Quetiapine—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000188	CcSEcCtD
Quetiapine—Asthenia—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.000187	CcSEcCtD
Quetiapine—Somnolence—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000187	CcSEcCtD
Quetiapine—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000186	CcSEcCtD
Quetiapine—Pruritus—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000185	CcSEcCtD
Quetiapine—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000183	CcSEcCtD
Quetiapine—Dizziness—Metformin—type 2 diabetes mellitus	2.81e-05	0.000183	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000182	CcSEcCtD
Quetiapine—Fatigue—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000182	CcSEcCtD
Quetiapine—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.78e-05	0.000181	CcSEcCtD
Quetiapine—Nausea—Valsartan—type 2 diabetes mellitus	2.77e-05	0.000181	CcSEcCtD
Quetiapine—Constipation—Ramipril—type 2 diabetes mellitus	2.76e-05	0.00018	CcSEcCtD
Quetiapine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.74e-05	0.000179	CcSEcCtD
Quetiapine—Nausea—Orlistat—type 2 diabetes mellitus	2.74e-05	0.000178	CcSEcCtD
Quetiapine—Asthenia—Losartan—type 2 diabetes mellitus	2.71e-05	0.000176	CcSEcCtD
Quetiapine—Vomiting—Metformin—type 2 diabetes mellitus	2.7e-05	0.000176	CcSEcCtD
Quetiapine—Rash—Metformin—type 2 diabetes mellitus	2.68e-05	0.000174	CcSEcCtD
Quetiapine—Dermatitis—Metformin—type 2 diabetes mellitus	2.67e-05	0.000174	CcSEcCtD
Quetiapine—Pruritus—Losartan—type 2 diabetes mellitus	2.67e-05	0.000174	CcSEcCtD
Quetiapine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000174	CcSEcCtD
Quetiapine—Headache—Metformin—type 2 diabetes mellitus	2.66e-05	0.000173	CcSEcCtD
Quetiapine—Perphenazine—CYP3A4—type 2 diabetes mellitus	2.65e-05	0.00819	CrCbGaD
Quetiapine—Dizziness—Irbesartan—type 2 diabetes mellitus	2.65e-05	0.000173	CcSEcCtD
Quetiapine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000172	CcSEcCtD
Quetiapine—Diarrhoea—Losartan—type 2 diabetes mellitus	2.58e-05	0.000168	CcSEcCtD
Quetiapine—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000167	CcSEcCtD
Quetiapine—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000167	CcSEcCtD
Quetiapine—Vomiting—Irbesartan—type 2 diabetes mellitus	2.55e-05	0.000166	CcSEcCtD
Quetiapine—Rash—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000165	CcSEcCtD
Quetiapine—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000165	CcSEcCtD
Quetiapine—Nausea—Metformin—type 2 diabetes mellitus	2.52e-05	0.000164	CcSEcCtD
Quetiapine—Headache—Irbesartan—type 2 diabetes mellitus	2.51e-05	0.000164	CcSEcCtD
Quetiapine—Dizziness—Losartan—type 2 diabetes mellitus	2.49e-05	0.000163	CcSEcCtD
Quetiapine—Vomiting—Losartan—type 2 diabetes mellitus	2.4e-05	0.000156	CcSEcCtD
Quetiapine—Promazine—CYP3A4—type 2 diabetes mellitus	2.39e-05	0.00738	CrCbGaD
Quetiapine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.38e-05	0.000155	CcSEcCtD
Quetiapine—Nausea—Irbesartan—type 2 diabetes mellitus	2.38e-05	0.000155	CcSEcCtD
Quetiapine—Rash—Losartan—type 2 diabetes mellitus	2.38e-05	0.000155	CcSEcCtD
Quetiapine—Dermatitis—Losartan—type 2 diabetes mellitus	2.38e-05	0.000155	CcSEcCtD
Quetiapine—Headache—Losartan—type 2 diabetes mellitus	2.36e-05	0.000154	CcSEcCtD
Quetiapine—Asthenia—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000151	CcSEcCtD
Quetiapine—Pruritus—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000149	CcSEcCtD
Quetiapine—Nausea—Losartan—type 2 diabetes mellitus	2.24e-05	0.000146	CcSEcCtD
Quetiapine—Clozapine—CYP3A4—type 2 diabetes mellitus	2.24e-05	0.00691	CrCbGaD
Quetiapine—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.21e-05	0.000144	CcSEcCtD
Quetiapine—Dizziness—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000139	CcSEcCtD
Quetiapine—Vomiting—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000134	CcSEcCtD
Quetiapine—Rash—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000133	CcSEcCtD
Quetiapine—Dermatitis—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000133	CcSEcCtD
Quetiapine—Headache—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000132	CcSEcCtD
Quetiapine—Nausea—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000125	CcSEcCtD
Quetiapine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-06	1.04e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.01e-06	1.03e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.01e-06	1.02e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-06	1.02e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1e-06	1.02e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.99e-07	1.02e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.98e-07	1.01e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	9.98e-07	1.01e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.97e-07	1.01e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.96e-07	1.01e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.95e-07	1.01e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.94e-07	1.01e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.92e-07	1.01e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.91e-07	1.01e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.86e-07	1e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.86e-07	1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.83e-07	9.99e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.8e-07	9.96e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.77e-07	9.93e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.75e-07	9.91e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	9.73e-07	9.89e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.71e-07	9.86e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.71e-07	9.86e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.61e-07	9.77e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.59e-07	9.74e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	9.56e-07	9.72e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.56e-07	9.72e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.5e-07	9.65e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.49e-07	9.64e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	9.46e-07	9.62e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.44e-07	9.59e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	9.38e-07	9.53e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.37e-07	9.52e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.37e-07	9.52e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.34e-07	9.49e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.33e-07	9.48e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.31e-07	9.46e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.3e-07	9.45e-06	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.29e-07	9.44e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.22e-07	9.37e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.21e-07	9.35e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.19e-07	9.34e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.19e-07	9.34e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	9.15e-07	9.3e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.15e-07	9.3e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.15e-07	9.29e-06	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.14e-07	9.29e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.14e-07	9.28e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.13e-07	9.28e-06	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.12e-07	9.27e-06	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.09e-07	9.24e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	9.09e-07	9.24e-06	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.06e-07	9.21e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.06e-07	9.2e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.04e-07	9.18e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.01e-07	9.16e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9e-07	9.14e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.98e-07	9.13e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.98e-07	9.13e-06	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.98e-07	9.12e-06	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.95e-07	9.1e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.95e-07	9.1e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.92e-07	9.07e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.9e-07	9.04e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.89e-07	9.04e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.87e-07	9.01e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.85e-07	8.99e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.84e-07	8.98e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.84e-07	8.98e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.81e-07	8.95e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	8.79e-07	8.94e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.7e-07	8.84e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.7e-07	8.84e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.65e-07	8.79e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	8.65e-07	8.79e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	8.63e-07	8.77e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	8.61e-07	8.75e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.61e-07	8.75e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.61e-07	8.75e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	8.6e-07	8.74e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.56e-07	8.7e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.54e-07	8.68e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.51e-07	8.65e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	8.5e-07	8.63e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.49e-07	8.62e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.47e-07	8.61e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.47e-07	8.61e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.46e-07	8.6e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.45e-07	8.59e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.44e-07	8.57e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.42e-07	8.56e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.4e-07	8.54e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.4e-07	8.53e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.39e-07	8.53e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.38e-07	8.52e-06	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.32e-07	8.45e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.32e-07	8.45e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	8.31e-07	8.45e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	8.3e-07	8.44e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.3e-07	8.44e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.29e-07	8.43e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.29e-07	8.43e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.28e-07	8.42e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.26e-07	8.39e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.25e-07	8.38e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	8.25e-07	8.38e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.24e-07	8.37e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.23e-07	8.36e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	8.22e-07	8.36e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	8.22e-07	8.36e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.19e-07	8.32e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.17e-07	8.3e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.15e-07	8.28e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.13e-07	8.26e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.12e-07	8.26e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.08e-07	8.21e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	8.03e-07	8.16e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.03e-07	8.16e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.02e-07	8.15e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.02e-07	8.15e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.01e-07	8.14e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.97e-07	8.09e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.95e-07	8.08e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	7.91e-07	8.04e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.9e-07	8.03e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.89e-07	8.02e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.88e-07	8e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.87e-07	8e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.85e-07	7.98e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.84e-07	7.97e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.82e-07	7.95e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.81e-07	7.94e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.79e-07	7.91e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.78e-07	7.9e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.75e-07	7.87e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.75e-07	7.87e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.73e-07	7.85e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	7.71e-07	7.83e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.7e-07	7.83e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.69e-07	7.81e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.68e-07	7.81e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.67e-07	7.79e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.67e-07	7.79e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.66e-07	7.78e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.65e-07	7.77e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.63e-07	7.75e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.62e-07	7.74e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.61e-07	7.73e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	7.56e-07	7.69e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	7.56e-07	7.69e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.55e-07	7.68e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.55e-07	7.67e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.53e-07	7.65e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	7.52e-07	7.64e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	7.51e-07	7.63e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	7.48e-07	7.6e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.45e-07	7.57e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	7.39e-07	7.51e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.34e-07	7.46e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.33e-07	7.45e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.23e-07	7.35e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.18e-07	7.3e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.17e-07	7.29e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.16e-07	7.27e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.09e-07	7.21e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.06e-07	7.18e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	7.06e-07	7.18e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.05e-07	7.17e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.04e-07	7.15e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.03e-07	7.14e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.02e-07	7.13e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.99e-07	7.11e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.99e-07	7.11e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.96e-07	7.07e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.93e-07	7.04e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.93e-07	7.04e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.92e-07	7.03e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.92e-07	7.03e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.91e-07	7.02e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.9e-07	7.01e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.88e-07	6.99e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.86e-07	6.97e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.79e-07	6.9e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.77e-07	6.88e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	6.76e-07	6.87e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.74e-07	6.85e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.62e-07	6.73e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.6e-07	6.71e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.6e-07	6.71e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	6.57e-07	6.68e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.53e-07	6.63e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.51e-07	6.62e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.51e-07	6.62e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.42e-07	6.52e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.37e-07	6.48e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.29e-07	6.39e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.15e-07	6.25e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.12e-07	6.22e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.95e-07	6.05e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.88e-07	5.98e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.86e-07	5.96e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	5.82e-07	5.91e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.75e-07	5.84e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.68e-07	5.77e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.65e-07	5.74e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.64e-07	5.73e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.49e-07	5.58e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.41e-07	5.49e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.4e-07	5.49e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	5.34e-07	5.42e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.32e-07	5.4e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.3e-07	5.39e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.29e-07	5.37e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.27e-07	5.36e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.22e-07	5.3e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.21e-07	5.29e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.17e-07	5.25e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.98e-07	5.07e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.95e-07	5.03e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.95e-07	5.03e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.9e-07	4.98e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.89e-07	4.97e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	4.89e-07	4.97e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.88e-07	4.96e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.86e-07	4.94e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.84e-07	4.91e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.82e-07	4.89e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.8e-07	4.88e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.52e-07	4.6e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.46e-07	4.53e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.78e-07	3.84e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.69e-07	3.75e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.48e-07	3.53e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.27e-07	2.31e-06	CbGpPWpGaD
